explore -WSS

explore

author：fashion 2025-09-29 17:02:13 - browse：83

Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Report: NIH

knowledge

WSS

Covid’s new normal has set in amid another rise in cases

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Lab trade group sues FDA to halt regulation of lab

Assistant physicians can help address the primary care shortage

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Wikipedia

explore

focus

Drug repurposing or repositioning? The language matters

Covid’s new normal has set in amid another rise in cases

ChatGPT in medicine: STAT answers readers' burning questions

Senate bill would ban some hospital facility fees

Psychedelics group wrestles with new pharma identity

How the messy conversation about Dolly changed bioethics

Dobbs anniversary: the lost opportunity of abortion as health care

Chamber of Commerce, DOJ clash in court over drug prices

Hollywood unions extend contract negotiations for actors

Patients, doctors press FTC to beef up hospital merger scrutiny

leisure time

Akili, maker of video game for ADHD, to be acquired for 34 million

Startling documents reveal new facets of Sacklers' opioid empire

Akili, maker of video game for ADHD, to be acquired for 34 million

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Adam's Biotech Scorecard: Do Sarepta's exon

FDA weighs limits of animal data in assessing artificial wombs

entertainment

focus

knowledge

explore